Dr. Schackman’s research interests include: cost and cost-effectiveness analyses conducted alongside clinical trials and cohort studies; simulation modelling of comparative effectiveness and cost-effectiveness outcomes; and implementation science research regarding budgetary and operational barriers to implementing evidence-based medical interventions.
Dr. Schackman is Associate Professor of Public Health and Chief of the Division of Health Policy in the Department of Public Health at Weill Cornell Medical College. His current research projects are in the following areas: 1) Economic evaluation of HIV testing and treatment. These studies evaluate the cost-effectiveness of HIV testing and treatment interventions in the US, and are conducted collaboratively with the NIDA-funded Clinical Trials Network and the NIAID-funded AIDS Clinical Trials Network. 2) Integrating substance abuse and medical treatment. These studies identify costs and evaluate the cost effectiveness of pharmacologic treatment of opioid dependence in medical settings, and of hepatitis C testing and medical treatment in substance abuse treatment settings. The results will be valuable to policy makers in overcoming financial barriers to integrating medical and substance abuse care. 3) Global health. These studies evaluate cost effectiveness and implementation requirements for scale up of HIV testing and treatment in Haiti, and provide mentoring and research training opportunities for Haitian trainees as part of a long-standing Cornell collaboration with the Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) Centers in Port-au-Prince.